Prefillable Syringe System Selection with West Synchrony™ S1

To view on-demand, please fill our short form

*
Captcha verification required

While the drug development team is in the process of working on the last details to optimize the drug, that is where the work for the packaging engineers really starts. A cumbersome journey of scouting and evaluation of all possible packaging options out there, followed by extensive testing and complex interpretation of the results. This process can take many months without assurance of comprehensively addressing all factors. Especially in the space of prefilled syringes which are regulated as combination products, the requirements are expansive and often ambiguous. This presentation introduces a groundbreaking innovation: An advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier. It will demonstrate how this system enables especially emerging biotechnology companies to significantly save time and resources, accelerating the pathway to clinical fill.


Key takeaways:

  • What exactly the West Synchrony™ S1 Prefillable Syringe System is
  • How it can help you streamline your process and get to your submission faster
  • How it can safe you time and money in your development process
  • How it can solve the supply chain challenges you face 

Dr. Bettine Boltres

Director Scientific Affairs, Integrated Systems

Dr. Bettine Boltres is a recognized thought leader in the industry, fostering scientific exchange between West and the pharmaceutical sector. She possesses extensive knowledge in glass, polymer, and rubber materials, which carries over in her expertise in combination products. Dr. Boltres is the author of the book “When Glass Meets Pharma” and serves as an expert for the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and various ISO working groups. Additionally, she plays an active role in the Parenteral Drug Association (PDA) and is serving on the PDA Board of Directors since 2019.